Predictors of ESA Use in the Non-Dialysis Chronic Kidney Disease Population with Anemia

2009 ◽  
Vol 111 (2) ◽  
pp. c141-c148 ◽  
Author(s):  
Allan J. Collins ◽  
Haifeng Guo ◽  
David T. Gilbertson ◽  
Brian D. Bradbury
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Chronic Kidney Disease Population

Opioid Use in the Nondialysis Chronic Kidney Disease Population

2021 ◽  
Vol 41 (1) ◽  
pp. 33-41
Author(s):  
Min Zhuo ◽  
Laura K. Triantafylidis ◽  
Jiahua Li ◽  
Julie M. Paik
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Opioid Use ◽  
Chronic Kidney Disease Population

scholarly journals Is polypharmacy an increasing burden in chronic kidney disease? The German experience

2019 ◽  
Vol 12 (5) ◽  
pp. 659-662 ◽  
Author(s):  
Kathrine Parker ◽  
Joanne Wong
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Current Practice ◽  
Practical Advice ◽  
Chronic Kidney Disease Population

Abstract This is a commentary article describing the key findings of the German chronic kidney disease (GCKD) study and how these relate to current practice. With the GCKD study showing high levels of polypharmacy, this article discusses ways to ensure that polypharmacy is appropriate and the difficulties faced within a chronic kidney disease population. Suggestions of ways to minimize medication burden in renal patients provide some practical advice for clinicians.

Sign in / Sign up

Export Citation Format

Share Document